Navigation Links
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Date:6/23/2009

ion other than education, circumcision, and condoms. It is obvious from the spread of the disease that these methods are not adequate. Existing treatments for individuals infected with HIV include anti-retroviral therapies that are effective but have serious medical side effects and are very expensive (upwards of $1,500/month). This cost is borne primarily by the individual and sometimes by third party insurance, local healthcare, federal or world health organizations. Development and distribution of an effective HIV/AIDS vaccine holds great promise. The GeoVax Vaccine would cost a fraction of the cost of current treatments and, to date, has not elicited serious adverse side effects in several human trials. A population vaccinated with an effective HIV-1 vaccine would be expected to significantly decrease the prevalence of AIDS over time.

About GeoVax Labs, Inc.

GeoVax Labs, Inc. is a biotechnology company, established to develop, manufacture, license and commercialize human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents. GeoVax's AIDS vaccine technology is the subject of 20 issued or filed patent applications. GeoVax AIDS vaccines are designed for use in uninfected people to prevent Acquired Immunodeficiency Disease (AIDS), caused by the virus known as HIV-1, should the person ever become infected. GeoVax AIDS vaccines also may be effective as therapeutics (treatment of people already infected with AIDS virus).

GeoVax's core AIDS vaccine technologies were developed by Dr. Harriet Robinson, Senior V.P. of Research and Development, through a collaboration of colleagues at Emory University's Vaccine Center, the National Institutes of Health (NIH), The Centers for Disease Control and Prevention (CDC) and GeoVax.

GeoVax's AIDS vaccines have moved forward in human clinical trials conducted by the HIV Vaccine Trials Network (HVTN)
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
7. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Reports Progress on Its AIDS Vaccine Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... COLORADO SPRINGS, Colo. , March 3, 2015 /PRNewswire/ ... in the development of cannabis-based medicine, today announced two ... preparation for its multiple global product launches, and CEO ... views in the Chicago HR Examiner. In ... C. Waits about leading a company in an ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... PharmaBiotech,s new report "Cardiovascular Drug Delivery - Technologies, ... Drug delivery to the cardiovascular system is ... anatomy and physiology of the vascular system; it supplies ... Drugs can be introduced into the vascular system for ...
(Date:3/3/2015)... YORK , March 3, 2015  Delcath ... specialty pharmaceutical and medical device company focused on ... primary and metastatic liver cancers, announces that the ... completed enrollment in 2009, have been submitted for ... clinical study utilized Melphalan Hydrochloride for Injection for ...
Breaking Medicine Technology:CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 2CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 3CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 4CBIS Momentum Continues: Company Opens Call Center In Preparation For New Product Releases & CEO Shares His 'Impressive And Insightful' Views With Columnist 5Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 2Global Cardiovascular Drug Delivery Technologies, Markets and Companies 2014-2024 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
... 5, 2011 OncoSec Medical Inc. (OTCBB: ONCS), ... treat solid tumor cancers, announced today the appointment ... will lead the development of the company,s proprietary ... (Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO ) ...
... 2011 Reportlinker.com announces that a ... in its catalogue: ... 2011 http://www.reportlinker.com/p0567542/International-Hyaluronic-Acid-Viscosupplementation-Physician-Survey-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic ... specialists were surveyed regarding their perceptions ...
Cached Medicine Technology:OncoSec Medical Appoints Engineering Leader 2OncoSec Medical Appoints Engineering Leader 3International Hyaluronic Acid Viscosupplementation Physician Survey 2011 2International Hyaluronic Acid Viscosupplementation Physician Survey 2011 3International Hyaluronic Acid Viscosupplementation Physician Survey 2011 4International Hyaluronic Acid Viscosupplementation Physician Survey 2011 5International Hyaluronic Acid Viscosupplementation Physician Survey 2011 6International Hyaluronic Acid Viscosupplementation Physician Survey 2011 7International Hyaluronic Acid Viscosupplementation Physician Survey 2011 8
(Date:3/3/2015)... (PRWEB) March 03, 2015 The first ... the National Sleep Foundation. The event brings recognition to ... over. , According to the Centers for ... problems of one form or another. Too little or ... risk of physical illness and depression, and even a ...
(Date:3/3/2015)... Today is International Ear Care Day, ... occasion to applaud and promote the launch of Make ... Organization (WHO) for stemming the threat of noise-induced hearing ... people to practice safe listening when they recreate, be ... sporting events, or engaging in other forms of entertainment. ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 The number ... since 1984 to about 15%. This increases to 50% ... (Bushnik T, Cook JL, Yuzpe AA, et al. Estimating ... 27: 738-46). Dr. Jason Hitkari, a reproductive endocrinologist and ... doctor of TCM and clinical director and founder of ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( ... radiology practice, today announced that Arlene Sussman, MD, a ... host a live webinar to explore how telemedicine best ... breast imaging services for women virtually anywhere. Click ... Imaging Service Line” on March 4, 2015 at 1:00 ...
(Date:3/3/2015)... Dallas, Texas (PRWEB) March 03, 2015 ... will serve as chairman of the upcoming Dallas Rhinoplasty ... 2015. The three day symposium, which is attended by ... designed to provide surgeons with detailed information on current ... and revision rhinoplasty surgery . , The ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 2Health News:Dr. Rod Rohrich to Chair 32nd Annual Dallas Rhinoplasty Symposium 3
... at Georgetown University Medical Center have discovered that a ... development of mammary cells by activating two critical cancer ... meeting of the American Association for Cancer Research (AACR), ... stem cells and that targeting this gene might provide ...
... Fewer and fewer people are dying after being severely ... his colleagues from Marburg University Hospital report in the ... in Germany sank continuously between 1999 and 2005, decreasing ... Deutsches rzteblatt on the trauma registry of the German ...
... Instrument Generates Real-Time In Vivo Data via Quantitative ... ... VisEn Medical, Inc., a leader,in fluorescence in vivo imaging, today announced ... FMT 2500 is based on VisEn,s,proprietary Fluorescence Molecular Tomography (FMT(TM)) technology,platform, ...
... April 14 PartnerWeekly, a SellingSource, LLC,company, ... billion-a-year cosmetics,industry with the signing of an ... makers of SensiClear, a revolutionary acne,treatment product ... the Janice,Dickinson Modeling Agency. PartnerWeekly is a ...
... community,pharmacy owners looking to pursue the pleasures of ... ApothecaryRx offers successful,independent retail pharmacy owners a smooth ... strength and independence of,the business -- and an ... ApothecaryRx pays fair market value for the ...
... the,nation,s 78 million baby boomers begin reaching age 65 ... that is too small and woefully unprepared to,meet their ... Institute of,Medicine. The report calls for bold initiatives starting ... specialists -- in the basics of,geriatric care and to ...
Cached Medicine News:Health News:Georgetown researchers find stem cell marker controls 2 key cancer pathways 2Health News:VisEn Medical Launches FMT(TM) 2500 - Next-Generation Fluorescence Imaging System 2Health News:PartnerWeekly and SensiClear(TM) Sign Online Marketing Pact 2Health News:ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors 2Health News:ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors 3Health News:ApothecaryRx Provides Exit Strategy for Boomer Pharmacy Businesses; Sustains Service and Communication Structure of Community Pharmacies to Improve Drug Compliance, Reduce Drug Errors 4Health News:Health Care Work Force Too Small, Unprepared for Aging Baby Boomers; Higher Pay, More Training, and Changes in Care Delivery Needed to Avert Crisis 2
... Model V-1000 is a new addition to the ... This high performance pump can achieve an ultimate ... of 64 L/min. Applications For ... concentrators Distillation applications from lab size ...
... is a powerful PTFE membrane vacuum pump designed ... Ideally suited for use with up to ... for instruments including vacuum ovens, concentrators, gel dryers, ... PEEK head resistant to chemicals and heat ...
... High Vacuum pumps deliver critical performance ... gas ballast control optimizes pump performance to ... glass allows for convenient checking of proper ... series of pumps is designed to work ...
... critical performance for all vacuum requirements. A ... performance to suit all applications. The large, ... of proper oil levels at a glance. ... to work with all Thermo Savant SpeedVac ...
Medicine Products: